Kevin Process Technologies is proud to announce investments to drive innovation and excellence in pharmaceutical technology equipment. With an investment of INR 100 million, the company is expanding its operations by establishing a new state-of-the-art manufacturing facility and a cutting-edge Customer Experience Centre. This expansion not only reflects Kevin’s growth but also reinforces India’s Make-in-India initiative, contributing significantly to the country’s exports and local manufacturing excellence.
Enhancing Manufacturing Capabilities
The newly built facility will be a game-changer for Kevin Process Technologies. Equipped with advanced fabrication and polishing technology, it will greatly enhance production capacity, reduce manufacturing lead times, and improve overall product quality.
By leveraging modern infrastructure, Kevin will be able to meet the growing demands of the pharmaceutical sector more efficiently. This facility will support the production of high-quality, innovative equipment for granulation, coating, and capsule filling, making it easier for the company to serve customers worldwide while maintaining the highest standards of safety and compliance.
Customer Experience Centre – A New Era of Collaboration
At the heart of this expansion is the Customer Experience Centre, a hub for fostering innovation and client collaboration. This dedicated space is designed to provide an immersive experience for customers, enabling them to validate, refine, and optimize their production processes using Kevin’s latest equipment and technology.
Key features include:
Factory Acceptance Testing (FAT) Area: Offering seamless validation of equipment before dispatch to ensure customers receive reliable and high-performing systems.
Advanced Process Lab: Allowing customers to test and fine-tune their processes using real-time equipment and process simulations.
Design & Sales Offices: Dedicated spaces for project planning, process design, and collaborative consultation with a customer-first approach.
Strengthening India’s Position in Global Pharma
Scheduled for completion by the end of 2025, this expansion is set to boost India’s footprint in the global pharmaceutical technology equipment industry. The new facilities will empower customers with better solutions, deeper insights, and enhanced manufacturing capacity while reinforcing Kevin’s commitment to Make-in-India and export excellence.
This strategic move aligns perfectly with Kevin’s long-term vision of technological leadership and customer-centric growth, making it a significant step in India’s journey to becoming a manufacturing hub.
Stay tuned for more updates as Kevin brings this exciting project to life!
Exclusive
IPA’s 10th Global Pharmaceutical Quality Summit
Articles
Key Insights and Best Practices By Dr. Tarun Chugh
A Seasoned Perspective By Manan Dave
By Todd Martin, Natoli Engineering Company, Inc
Infocus
Presented by UhImann India, Optima, and Glat
Kevin Process Technologies
Tests and Process Optimization in Hyderabad